These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18044983)

  • 1. Controlling endemic cholera with oral vaccines.
    Longini IM; Nizam A; Ali M; Yunus M; Shenvi N; Clemens JD
    PLoS Med; 2007 Nov; 4(11):e336. PubMed ID: 18044983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis.
    Ali M; Emch M; von Seidlein L; Yunus M; Sack DA; Rao M; Holmgren J; Clemens JD
    Lancet; 2005 Jul 2-8; 366(9479):44-9. PubMed ID: 15993232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of oral cholera vaccine as a vaccine probe to define the geographical dimensions of person-to-person transmission of cholera.
    Ali M; Kim DR; Kanungo S; Sur D; Manna B; Digilio L; Dutta S; Marks F; Bhattacharya SK; Clemens J
    Int J Infect Dis; 2018 Jan; 66():90-95. PubMed ID: 29174695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herd protection of unvaccinated adults by oral cholera vaccines in rural Bangladesh.
    Ali M; Kim P; Zaman K; Clemens J
    Int Health; 2019 May; 11(3):229-234. PubMed ID: 30496408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of a killed whole-cell oral cholera vaccine in Bangladesh: further follow-up of a cluster-randomised trial.
    Ali M; Qadri F; Kim DR; Islam MT; Im J; Ahmmed F; Khan AI; Zaman K; Marks F; Kim JH; Clemens JD
    Lancet Infect Dis; 2021 Oct; 21(10):1407-1414. PubMed ID: 34146473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Field trial of a locally produced, killed, oral cholera vaccine in Vietnam.
    Trach DD; Clemens JD; Ke NT; Thuy HT; Son ND; Canh DG; Hang PV; Rao MR
    Lancet; 1997 Jan; 349(9047):231-5. PubMed ID: 9014909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact and cost-effectiveness of controlling cholera through the use of oral cholera vaccines in urban Bangladesh: A disease modeling and economic analysis.
    Khan AI; Levin A; Chao DL; DeRoeck D; Dimitrov DT; Khan JAM; Islam MS; Ali M; Islam MT; Sarker AR; Clemens JD; Qadri F
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006652. PubMed ID: 30300420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unmasking herd protection by an oral cholera vaccine in a cluster-randomized trial.
    Ali M; Qadri F; Kim DR; Islam T; Im J; Ahmmed F; Chon Y; Islam Khan A; Zaman K; Marks F; Clemens JD
    Int J Epidemiol; 2019 Aug; 48(4):1252-1261. PubMed ID: 30968110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effectiveness of different strategies of oral cholera vaccination in bangladesh: a modeling study.
    Dimitrov DT; Troeger C; Halloran ME; Longini IM; Chao DL
    PLoS Negl Trop Dis; 2014 Dec; 8(12):e3343. PubMed ID: 25473851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The case for reactive mass oral cholera vaccinations.
    Reyburn R; Deen JL; Grais RF; Bhattacharya SK; Sur D; Lopez AL; Jiddawi MS; Clemens JD; von Seidlein L
    PLoS Negl Trop Dis; 2011 Jan; 5(1):e952. PubMed ID: 21283614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving immunization approaches to cholera.
    Saha A; Rosewell A; Hayen A; MacIntyre CR; Qadri F
    Expert Rev Vaccines; 2017 Mar; 16(3):235-248. PubMed ID: 27805467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis.
    Jeuland M; Cook J; Poulos C; Clemens J; Whittington D;
    Value Health; 2009 Sep; 12(6):899-908. PubMed ID: 19824189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing immunization schedules in endemic cholera regions: cost-effectiveness assessment of vaccination strategies for cholera control in Bangladesh.
    Zeng W; Cui Y; Jarawan E; Avila C; Li G; Turbat V; Bouey J; Farag M; Mutasa R; Ahn H; Sun D; Shen J
    Vaccine; 2021 Oct; 39(43):6356-6363. PubMed ID: 34579976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The design and analysis of cholera vaccine trials: recent lessons from Bangladesh.
    Clemens J; Sack D; Rao M; Chakraborty J; Kay B; Ahmed F; Khan MR; van Loon FP; Svennerholm AM; Holmgren J
    Int J Epidemiol; 1993 Aug; 22(4):724-30. PubMed ID: 8225749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When, how, and where can oral cholera vaccines be used to interrupt cholera outbreaks?
    Clemens J; Holmgren J
    Curr Top Microbiol Immunol; 2014; 379():231-58. PubMed ID: 24402712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired immune response to natural infection as a correlate of vaccine failure in a field trial of killed oral cholera vaccines.
    Clemens J; Rao M; Sack D; Ahmed F; Khan MR; Chakraborty J; Kay B; Huda S; Yunus M; van Loon F
    Am J Epidemiol; 1995 Oct; 142(7):759-64. PubMed ID: 7572947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Field trial of oral cholera vaccines in Bangladesh.
    Clemens JD; Sack DA; Harris JR; Chakraborty J; Khan MR; Stanton BF; Kay BA; Khan MU; Yunus M; Atkinson W
    Lancet; 1986 Jul; 2(8499):124-7. PubMed ID: 2873397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine Protection of Bangladeshi infants and young children against cholera: implications for vaccine deployment and person-to-person transmission.
    Ali M; Emch M; Yunus M; Sack D; Lopez AL; Holmgren J; Clemens J
    Pediatr Infect Dis J; 2008 Jan; 27(1):33-7. PubMed ID: 18162935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar.
    Schaetti C; Weiss MG; Ali SM; Chaignat CL; Khatib AM; Reyburn R; Duintjer Tebbens RJ; Hutubessy R
    PLoS Negl Trop Dis; 2012; 6(10):e1844. PubMed ID: 23056660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study.
    Khatib AM; Ali M; von Seidlein L; Kim DR; Hashim R; Reyburn R; Ley B; Thriemer K; Enwere G; Hutubessy R; Aguado MT; Kieny MP; Lopez AL; Wierzba TF; Ali SM; Saleh AA; Mukhopadhyay AK; Clemens J; Jiddawi MS; Deen J
    Lancet Infect Dis; 2012 Nov; 12(11):837-44. PubMed ID: 22954655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.